GalenusCare Opens NJ HQ to Tackle Senior Medication Crisis

MOUNT LAUREL, NJ – March 24, 2026 – A new front in the battle for senior healthcare safety has opened in Mount Laurel, where Galenus Precision Pharmacy, operating as GalenusCare, has unveiled its national headquarters. The grand opening, supported by state economic initiatives and attended by local leaders, marks a significant expansion of the company's mission to protect America's most vulnerable patients from a pervasive and often silent threat: polypharmacy, the simultaneous use of multiple medications.

The new facility is poised to serve as the nerve center for GalenusCare’s advanced medication management services, specifically designed for Programs of All-Inclusive Care for the Elderly (PACE) and hospice providers. By combining high-tech analytics with high-touch pharmacist intervention, the company aims to transform how complex medication regimens are managed, shifting from a reactive model of care to a proactive strategy of prevention.

The Silent Epidemic of Medication Overload

For millions of older Americans, the medicine cabinet represents a paradox of modern healthcare. While individual drugs are prescribed to manage chronic conditions and improve health, their cumulative effect can be devastating. This condition, known as polypharmacy, is defined by the use of five or more prescription medications and affects a staggering 42% of adults over 65. As the number of pills increases, so does the risk of preventable and predictable adverse drug events.

The consequences are dire. According to national health data, an estimated 750 older adults are hospitalized each day due to medication-related complications, and more than 400 die. These events are not merely side effects; they are a leading cause of falls, cognitive impairment, emergency department visits, and premature death. Polypharmacy accounts for nearly 30% of all hospital admissions in the U.S., placing an immense burden on patients, their families, and the healthcare system.

The problem is particularly acute in settings like PACE and hospice, where patients are medically frail and manage multiple complex, chronic conditions. For these individuals, a seemingly minor drug interaction can trigger a cascade of health crises, undermining their quality of life and contradicting the core mission of their care providers.

A New Prescription for Safety: Precision and Technology

GalenusCare proposes a fundamental shift away from this precarious status quo. The company's approach, termed “precision pharmacy,” moves beyond simple, one-to-one drug interaction checks, which often miss the cumulative risk of a complex regimen. Instead, it employs advanced analytics and AI-powered technology to evaluate a patient's entire medication list simultaneously, identifying hidden risks from drug-drug, drug-gene, and drug-disease interactions.

“This opening marks an important step forward in our mission to redefine medication management for medically complex populations,” said Dr. Calvin Knowlton, CEO and Co-Founder of GalenusCare, at the ribbon-cutting ceremony. “Our purpose is to shift the paradigm from preference-based trial and error medication regimens to using science and advanced pharmacist practitioners to optimize medication combinations that are both personalized and precise.”

This mission is deeply rooted in the founders' extensive history. Dr. Calvin Knowlton and President & Co-Founder Dr. Orsula Knowlton are nationally recognized figures in pharmacy innovation. They previously founded and led Tabula Rasa HealthCare, a publicly traded company renowned for its pioneering work in medication risk mitigation, and excelleRx, a hospice medication management service sold for over $269 million. Their decades of experience are focused on empowering pharmacists to prevent harm before it occurs.

GalenusCare’s model integrates specialized pharmacists directly into care team workflows. These clinicians use the company's analytical tools to provide actionable recommendations, such as changing administration times, suggesting therapeutic substitutions, or initiating a “deprescribing” process to safely eliminate unnecessary medications.

“Medication management should strengthen care—not complicate it,” stated Dr. Orsula Knowlton. “Our model integrates pharmacist collaboration and clinical insights directly into care team workflows, helping teams deliver safer, higher-quality care with greater efficiency.”

New Jersey's Growing Bet on Health-Tech Innovation

The establishment of GalenusCare’s national headquarters in Mount Laurel is not just a corporate milestone; it’s a testament to New Jersey's strategic effort to cultivate a thriving innovation economy. The project received partial support from the New Jersey Economic Development Authority (NJEDA), an agency tasked with fostering business growth and job creation in the state.

The partnership highlights a growing trend of public-private collaboration to solve critical healthcare challenges while stimulating regional economic development. The ribbon-cutting ceremony drew a host of local dignitaries, including state Senator Troy Singleton, Assemblywoman Carol Murphy, and Mount Laurel Township Council Member Fozia Janjua, signaling strong local and state-level backing for the venture.

“With NJEDA’s support, GalenusCare is advancing accessible, high‑quality care for New Jersey residents while expanding its reach nationwide,” said NJEDA Chief Economic Transformation Officer Kathleen Coviello. “We are proud that Dr. Knowlton continues to choose New Jersey as the place to build and grow his companies. Founders like him are essential to strengthening our innovation economy, creating good‑paying jobs, and reinforcing New Jersey’s leadership in health care and technology.”

By attracting companies like GalenusCare, New Jersey is cementing its reputation as a hub for the life sciences and healthcare technology sectors, leveraging its deep talent pool and strategic location to drive both medical and economic progress.

Redefining Care in PACE and Hospice

GalenusCare’s focus on PACE and hospice providers is highly strategic. These organizations operate under a value-based care model, where they are financially responsible for the total health and well-being of their patients. Preventing a single fall, emergency room visit, or hospitalization directly translates into better patient outcomes and significant cost savings.

PACE programs provide comprehensive medical and social services to older adults who would otherwise require nursing home-level care, allowing them to live safely in their communities. Medication management is a cornerstone of this model, but the complexity of their participants' needs presents a constant challenge. By offering proactive risk mitigation and expert pharmacist collaboration, GalenusCare provides these programs with a powerful tool to enhance safety and efficiency.

Similarly, in hospice care, the focus is on comfort and quality of life. Inappropriate medications can cause distressing symptoms that run counter to the goals of palliative care. GalenusCare’s services, which include providing personalized symptom kits at admission for timely relief, help ensure that medication regimens are perfectly aligned with the patient's end-of-life care plan.

By embedding its precision pharmacy services within these specialized care models, GalenusCare is not merely selling a product but becoming an integral partner in delivering safer, more effective, and more humane care to those who need it most.